Gyre Therapeutics
South San Francisco
About Gyre Therapeutics
Gyre Therapeutics is a research and clinical development biopharmaceutical company. They focus on addressing unmet medical needs in rare disorders of the complement and coagulation systems. They create novel catalytic biopharmaceutical products based on engineered human proteases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $100K – $500K
- Total funding: $321.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2025)
- Ticker: nasdaq:GYRE
- Website: gyretx.com
- Phone: +1 844-556-7246
Industries & Categories
Biopharma, Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/gyre-therapeutics-26555 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.